ReviewAbdominal radiology (New York)2026
Multimodal imaging features to diagnose abdominal complications of sickle cell disease.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) is a hereditary hemoglobinopathy, marked by chronic hemolysis and recurrent vaso-occlusive crises, which frequently leads to a wide range of abdominal complications. Sickled erythrocytes have reduced deformability and increased adhesion to vessel walls, leading to chronic vascular occlusion, inflammation, and hemolysis. Comprehensive imaging plays a pivotal role in the early detection and assessment of these complications, thereby mitigating morbidity and severe outcomes. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the three modalities commonly used on SCD patients to evaluate hepatosplenic involvement, renal pathology, pancreatobiliary disorders, gastrointestinal ischemia, extramedullary hematopoiesis, and genital abnormalities. The US is a first-line imaging tool due to its accessibility and low cost. CT offers high-resolution, cross-sectional imaging and is often utilized in emergency settings. MRI, with its superior soft tissue contrast, is excellent for problem-solving. A thorough understanding of the abdominal manifestations of SCD is essential for radiologists to provide accurate diagnoses, guide clinical decision-making, and reduce morbidity and mortality. This review highlights the most significant imaging findings from SCD abdominal complications, emphasizing their clinical implications, underlying pathophysiology, and radiological features in all three modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.